Automedika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 296,224 | 265,592 | 254,752 | 264,586 | 283,455 | 301,591 | 297,710 | 345,232 |
| Profit before tax | - | -5,115 | 7,044 | -7,812 | -7,593 | -4,134 | -2,056 | -22,429 |
| Net profit | 6,397 | -5,115 | 6,768 | -7,812 | -7,593 | -4,134 | -2,056 | -22,429 |
| Equity | 44,463 | 46,339 | 53,107 | 45,296 | 37,703 | 33,569 | 31,513 | 9,085 |
| Liabilities | 68,207 | 58,566 | 54,253 | 44,991 | 52,238 | 57,242 | 45,950 | 49,085 |
| Non-current assets | 17,948 | 15,436 | 15,273 | 12,870 | 7,564 | 4,161 | 3,076 | 5,506 |
| Current assets | 94,722 | 89,469 | 92,087 | 77,417 | 82,377 | 86,650 | 74,387 | 52,664 |
| Total assets | 112,670 | 104,905 | 107,360 | 90,287 | 89,941 | 90,811 | 77,463 | 58,170 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 31,972 | 37,591 | 48,809 |
| Social insurance contributions | - | - | - | - | - | 23,558 | 25,765 | 33,635 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -7.0% | -10.3% | -4.1% | +3.9% | +7.1% | +6.4% | -1.3% | +16.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.7% | -4.9% | 6.3% | -8.7% | -8.4% | -4.6% | -2.7% | -38.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.4% | -11.0% | 12.7% | -17.2% | -20.1% | -12.3% | -6.5% | -246.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.2% | -1.9% | 2.7% | -3.0% | -2.7% | -1.4% | -0.7% | -6.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -1.9% | 2.8% | -3.0% | -2.7% | -1.4% | -0.7% | -6.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.3 | 1.0 | 1.0 | 1.4 | 1.7 | 1.5 | 5.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 29,871 | 25,703 | 25,057 | 27,851 | 25,575 | 28,953 | 29,771 | 31,149 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Automedika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-17 | 2026-03-27 | 48.28 |
| 2026-02-18 | 2026-02-22 | 48.28 |
| 2026-01-21 | 2026-02-12 | 0.17 |
| 2025-11-18 | 2025-12-14 | 23.82 |
| 2022-05-17 | 2022-05-25 | 1.15 |
Automedika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-22 | 2026-04-27 | 0.01 |
| 2026-04-19 | 2026-04-21 | 27.43 |
| 2026-04-17 | 2026-04-18 | 27.26 |
| 2025-02-06 | 2025-02-14 | 8.3 |
| 2025-01-28 | 2025-02-05 | 9.6 |
| 2025-01-25 | 2025-01-27 | 463.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Automedika, UAB (code 150056725) is a Private Limited Liability Company operating in repair and maintenance of motor vehicles. In 2025, revenue reached EUR 345.2K, increasing by 16.0% year on year and by 14.5% compared with 2023. Despite this top-line growth, the company posted a net loss of EUR 22.4K, compared with a loss of EUR 2.1K in 2024 and EUR 4.1K in 2023. The profit margin weakened to -6.5% in 2025 from -0.7% in 2024. Total assets declined to EUR 58.2K, while equity fell sharply to EUR 9.1K and liabilities were EUR 49.1K. The equity ratio stood at 15.6%, indicating a modest capital base, and the debt burden remained elevated relative to equity. Asset turnover was 5.93x, showing that the asset base generated relatively high revenue. Revenue per employee was EUR 31.4K, while profit per employee was EUR -2.0K. Overall, 2025 reflects higher turnover but a materially weaker profitability position and a smaller balance sheet.